HER2/Neu Positive Completed Phase 2 Trials for Temsirolimus (DB06287)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00376688Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast CancerTreatment